Pneumonia vaccination timing in relation to starting conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
| Autor: | Costello RE; Centre for Epidemiology Versus Arthritis, The University of Manchester, Manchester, Manchester, UK ruth.costello@manchester.ac.uk., Humphreys JH; Centre for Epidemiology Versus Arthritis, The University of Manchester, Manchester, Manchester, UK., Winthrop KL; Division of Infectious Diseases, Oregon Health & Science University, Portland, Oregon, USA., Dixon WG; Centre for Epidemiology Versus Arthritis, The University of Manchester, Manchester, Manchester, UK.; Department of Rheumatology, Salford Royal NHS Foundation Trust, Salford, UK. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Annals of the rheumatic diseases [Ann Rheum Dis] 2020 Dec; Vol. 79 (12), pp. 1665-1666. Date of Electronic Publication: 2020 Jun 26. |
| DOI: | 10.1136/annrheumdis-2020-217255 |
| Abstrakt: | Competing Interests: Competing interests: WGD has received consultancy fees from Bayer, Abbvie and Google unrelated to this work. All other authors have no conflicts of interest. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|